QLi5 Therapeutics GmbH (QLi5), a spin-off from the Max Planck Institute for Biochemistry, has successfully completed a ...

Abu Dhabi Customs (ADC) today announced a strategic partnership with CrimsonLogic, a wholly-owned subsidiary of PSA International, to develop the Integrated Customs Operations System (ICOS), an ...

StarkAge Therapeutics announces research collaboration with Gustave Roussy to advance senolytic therapies in digestive cancers: Lille, France Thursday, January 29, 2026, 11:00 Hrs ...

Funding advances Proteasome Inhibitor ADC Platform targeting cancer, inflammatory and autoimmune disordersQLi5 Therapeutics GmbH (QLi5), a spin-off ...

The tragedy of this political promiscuity lies not merely in its shamelessness but in its complete disregard for the ...

An ancient, fundamental cooling technique gets a new, more-efficient implementation via an innovative fiber matrix.

LigaChem Biosciences will attend the 44th JP Morgan Healthcare Conference (JPM 2026), the world's largest pharmaceutical and biotech investment event, to be held in San Francisco from the 12th to the ...

Company expands its ADC pipeline and patent estate for novel, differentiated ADCs New pipeline candidate AKTX-102 leverages ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS) ...

Legit.ng journalist Adekunle Dada has over 8 years of experience covering metro, government policy, and international issues Imo State - Former Imo State governor, Rt. Hon. Emeka Ihedioha, has ...

MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

The 2026 transfer portal cycle is moving faster than anything college football has seen before. A condensed, two-week entry window has compressed timelines, forcing staffs to operate with urgency as ...